Terns PharmaceuticalsTERN

那斯達克 · USD
5.47
-0.36
(-6.17%)
收盤 08/02 03:59 (UTC+8)
盤後 
5.50 
+0.03 
(+0.55%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
27,42725,94924,939-25,446-33,18421,15924,15716,828
研發費用
18,72018,00415,16918,35218,58717,45914,83114,15117,05610,658
推銷及管理費用
8,7077,9459,7707,1856,8596,59918,3537,0087,1016,170
非經常性項目費用
----------
其他營業費用
----------
營業利益
-27,427
-25,949
-24,939
-25,537
-25,446
-24,058
-33,184
-21,159
-24,157
-16,828
其他收入及費用
3,6074,1903,0562,8623,1703,0883,4753,3352,6891,324
利息費用
----------
稅前純益
-23,820
-21,759
-21,883
-22,675
-22,276
-20,970
-29,709
-17,824
-21,468
-15,504
所得稅
884062619749587260318
稅後純益
-23,908
-21,799
-21,945
-22,736
-22,373
-21,019
-29,767
-17,896
-21,528
-15,822
基本每股稅後盈餘(元)
-0.26-0.24-0.28-0.31-0.30--0.42-0.25-0.31-0.29
稀釋每股稅後盈餘(元)
-0.26-0.23-0.28-0.31-0.30-0.29-0.42-0.25-0.31-0.17
基本平均股數(千股)
91473.0091240.0077819.0074459.0074399.00-71530.0071364.0069778.0054696.00
稀釋平均股數(千股)
91473.0091240.0077819.0074459.0074399.00-71530.0071364.0069778.0054696.00
還原基本每股稅後盈餘(元)
-0.26-0.24-0.28-0.31-0.30--0.42-0.25-0.31-0.29
還原稀釋每股稅後盈餘(元)
-0.26-0.23-0.28-0.31-0.30-0.29-0.42-0.25-0.31-0.17
還原基本平均股數(千股)
91,47391,24077,81974,45974,399-71,53071,36469,77854,696
還原稀釋平均股數(千股)
91,47391,24077,81974,45974,399-71,53071,36469,77854,696
EBITDA(千元)
-23,760-22,706-21,681-22,445-22,400-22,249-31,236-18,582-22,052-15,837

大家都在看

HOT